WallStreetZenWallStreetZen

NASDAQ: CODX
Co Diagnostics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CODX

Based on 1 analyst offering 12 month price targets for Co Diagnostics Inc.
Min Forecast
$2.50+117.39%
Avg Forecast
$2.50+117.39%
Max Forecast
$2.50+117.39%

Should I buy or sell CODX stock?

Based on 1 analyst offering ratings for Co Diagnostics Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CODX stock forecasts and price targets.

CODX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-15

1 of 1

Forecast return on equity

Is CODX forecast to generate an efficient return?

Forecast return on assets

Is CODX forecast to generate an efficient return on assets?

CODX revenue forecast

What is CODX's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$6.0M-11.92%

CODX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
CODX$1.15$2.50+117.39%Hold
OWLT$4.02N/AN/A
PXDT$2.46N/AN/A
LNSR$3.18N/AN/A
LUCD$0.72$2.75+280.36%Strong Buy
View Top Medical Device Stocks

Co Diagnostics Stock Forecast FAQ

Is Co Diagnostics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CODX) stock is to Hold CODX stock.

Out of 1 analyst, 0 (0%) are recommending CODX as a Strong Buy, 0 (0%) are recommending CODX as a Buy, 1 (100%) are recommending CODX as a Hold, 0 (0%) are recommending CODX as a Sell, and 0 (0%) are recommending CODX as a Strong Sell.

If you're new to stock investing, here's how to buy Co Diagnostics stock.

What is CODX's revenue growth forecast for 2024-2024?

(NASDAQ: CODX) Co Diagnostics's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Co Diagnostics's revenue in 2024 is $6,812,038.

In 2024, CODX is forecast to generate $187,558,008 in revenue, with the lowest revenue forecast at $187,558,008 and the highest revenue forecast at $187,558,008.

What is CODX's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: CODX) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 9.14%.

What is CODX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CODX price target, the average CODX price target is $2.50, with the highest CODX stock price forecast at $2.50 and the lowest CODX stock price forecast at $2.50.

The Wall Street analyst predicted that Co Diagnostics's share price could reach $2.50 by Mar 15, 2025. The average Co Diagnostics stock price prediction forecasts a potential upside of 117.39% from the current CODX share price of $1.15.

What is CODX's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: CODX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.